{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:51:21Z","timestamp":1769827881621,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.clim.2010.05.009","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T08:46:36Z","timestamp":1276332396000},"page":"447-455","source":"Crossref","is-referenced-by-count":43,"title":["Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy"],"prefix":"10.1016","volume":"136","author":[{"given":"Tatsuyuki","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Hiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Takiue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2010.05.009_bib1","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1681\/ASN.2005020134","article-title":"IgA nephropathy","volume":"16","author":"Barratt","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0272-6386(88)80022-2","article-title":"The immunohistology of IgA nephropathy","volume":"12","author":"Jennette","year":"1988","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clim.2010.05.009_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2005.03.010","article-title":"IgA: an immune glycoprotein","volume":"116","author":"Yoo","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2010.05.009_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1046\/j.1523-1755.2001.0590031077.x","article-title":"Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy","volume":"59","author":"Hiki","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0272-6386(03)00743-1","article-title":"IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy","volume":"42","author":"Horie","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clim.2010.05.009_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbrc.2006.09.075","article-title":"Structural analyses of O-glycan sugar chains on IgA1 hinge region using SELDI-TOFMS with various lectins","volume":"350","author":"Takahashi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2010.05.009_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2249.1995.tb03724.x","article-title":"Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy","volume":"100","author":"Allen","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2010.05.009_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1681\/ASN.V104760","article-title":"Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy","volume":"10","author":"Hiki","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/ndt\/12.4.701","article-title":"Leucocyte beta 1, 3 galactosyltransferase activity in IgA nephropathy","volume":"12","author":"Allen","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2010.05.009_bib11","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1074\/jbc.M211097200","article-title":"Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2","volume":"278","author":"Iwasaki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2010.05.009_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1074\/jbc.M109060200","article-title":"Cloning and expression of human core 1 beta1, 3-galactosyltransferase","volume":"277","author":"Ju","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2010.05.009_bib13","doi-asserted-by":"crossref","first-page":"16613","DOI":"10.1073\/pnas.262438199","article-title":"A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase","volume":"99","author":"Ju","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.clim.2010.05.009_bib14","doi-asserted-by":"crossref","first-page":"47724","DOI":"10.1074\/jbc.M205839200","article-title":"Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1, 3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan","volume":"277","author":"Kudo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2010.05.009_bib15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/glycob\/9.11.1213","article-title":"Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2, 6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens","volume":"9","author":"Ikehara","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.clim.2010.05.009_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1432-1327.1999.00733.x","article-title":"Molecular cloning and expression of Galbeta1, 3GalNAc alpha2, 3-sialyltransferase from human fetal liver","volume":"265","author":"Shang","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.clim.2010.05.009_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-2143(99)90008-2","article-title":"Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?","volume":"133","author":"Leung","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.clim.2010.05.009_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.2000.2613","article-title":"Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry","volume":"271","author":"Odani","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2010.05.009_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2007.08.009","article-title":"Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy","volume":"125","author":"Ding","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2010.05.009_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.sbi.2006.09.001","article-title":"Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families","volume":"16","author":"Narimatsu","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.clim.2010.05.009_bib21","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1681\/ASN.2006060658","article-title":"O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy","volume":"17","author":"Smith","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib22","first-page":"227","article-title":"The clinical course of mesangial IgA associated nephropathy in adults","volume":"53","author":"Nicholls","year":"1984","journal-title":"Q. J. Med."},{"key":"10.1016\/j.clim.2010.05.009_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/03655230410003369","article-title":"Clinical involvement of the tonsillar immune system in IgA nephropathy","author":"Bene","year":"2004","journal-title":"Acta Otolaryngol. Suppl."},{"key":"10.1016\/j.clim.2010.05.009_bib24","first-page":"147","article-title":"Tonsillectomy does not prevent a progressive course in IgA nephropathy","volume":"51","author":"Rasche","year":"1999","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib25","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1523-1755.2003.00935.x","article-title":"The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy","volume":"63","author":"Xie","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2215\/CJN.00310108","article-title":"Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study","volume":"3","author":"Komatsu","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clim.2010.05.009_bib28","first-page":"108","article-title":"Morphological and morphometrical analysis of circulation in hypertension and ischemic kidney","author":"Suwa","year":"1971"},{"key":"10.1016\/j.clim.2010.05.009_bib29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1523-1755.2005.00494.x","article-title":"Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice","volume":"68","author":"Kobayashi","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9440(10)65618-0","article-title":"Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells","volume":"153","author":"Takahashi","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2010.05.009_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/art.21524","article-title":"Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis","volume":"54","author":"Sunahori","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2010.05.009_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-4165(99)00168-3","article-title":"Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions","volume":"1473","author":"Amado","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2010.05.009_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-4165(00)00020-9","article-title":"Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells","volume":"1474","author":"Samyn-Petit","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2010.05.009_bib34","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1101\/gr.1293003","article-title":"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment","volume":"13","author":"Clark","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.clim.2010.05.009_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2007.11.121","article-title":"Immunocytochemical analysis for intracellular dynamics of C1GalT associated with molecular chaperone, Cosmc","volume":"366","author":"Narimatsu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2010.05.009_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.ki.5002040","article-title":"Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model","volume":"71","author":"Tanabe","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/4371252a","article-title":"Protein glycosylation: chaperone mutation in Tn syndrome","volume":"437","author":"Ju","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2010.05.009_bib38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ndt\/gfg108","article-title":"Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients","volume":"18","author":"Itoh","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2010.05.009_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-3083.2008.02204.x","article-title":"Activity of alpha2, 6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy","volume":"69","author":"Ding","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2010.05.009_bib40","first-page":"629","article-title":"IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1","volume":"118","author":"Suzuki","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2010.05.009_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2796.2005.01558.x","article-title":"Peripheral B lymphocyte beta1, 3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy","volume":"258","author":"Qin","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clim.2010.05.009_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000112922","article-title":"Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy","volume":"31","author":"Mestecky","year":"2008","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.clim.2010.05.009_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.semnephrol.2007.10.009","article-title":"IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy","volume":"28","author":"Novak","year":"2008","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib45","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.V86915","article-title":"Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy","volume":"8","author":"Kokubo","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib46","first-page":"1668","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2010.05.009_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000422409","article-title":"Serum IgA and macromolecular IgA reacting with mesangial matrix components","volume":"104","author":"Coppo","year":"1993","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.clim.2010.05.009_bib48","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1523-1755.2005.67107.x","article-title":"IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells","volume":"67","author":"Novak","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2010.05.009_bib49","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661610006029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661610006029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T11:05:08Z","timestamp":1635505508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661610006029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1521661610006029"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2010.05.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}